The Digest’s 2026 Multi-Slide Guide to Corteva

Corteva is on track to separate into two independent market leaders by late 2026, with the “New Corteva SpinCo” focusing on advanced genetics, gene editing, and biofuels. Commercially, the company raised its full-year 2025 operating EBITDA guidance to 3.80–3.90 billion, driven by strong seed volumes in North America and new crop protection product gains. The preliminary 2026 outlook projects mid-single-digit growth, leveraging operational efficiencies and a technology-driven portfolio including biologicals and differentiated crop protection solutions.